Girum Tesfaye Tesfaye Kiya

Mr. Girum Tesfaye Tesfaye Kiya

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in Journal of Hospital Infection
Verified
Journal Article
Closed access
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
ZMZ. Mekonnen
Z. Mekonnen
TMT. Melaku
T. Melaku
ETE. Tegene
E. Tegene
EGE.K. Gudina
E.K. Gudina
GAGemeda Abebe
Gemeda Abebe

16 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
GAGemeda Abebe
Gemeda Abebe
ZMZeleke Mekonnen
Zeleke Mekonnen
ETEdosa Tadasa
Edosa Tadasa
GMGedion Milkias
Gedion Milkias
EAElsah Tegene Asefa
Elsah Tegene Asefa
Background: Disseminated intravascular coagulation (DIC) is a common complication in sepsis patients which exacerbates patient outcomes. The prevalence and outcomes of DIC in sepsis is wide-ranging and highly depends on the severity of the disease and diagnostic approaches utilized. Varied diagnostic criteria of DIC have been developed and their performance in diagnosis and prognosis is not consistent. Therefore, this study aimed to determine the score positivity rate and performance of different DIC scoring systems in predicting mortality in sepsis patients. Methods: Four databases, including Medline (through PubMed), Scopus, Embase, and Web of Science were searched for studies that determined DIC in sepsis patients using the three scoring systems namely: the International Society on Thrombosis and Hemostasis DIC (ISTH-DIC) criteria, the Japanese association for acute medicine DIC (JAAM-DIC) criteria, and the sepsis-induced coagulopathy (SIC) criteria. A random-effect meta-analysis was performed with a 95% confidence interval (CI). Subgroup analysis was conducted in view of geographic region and sepsis stages. the protocol was submitted to the Prospective Register for Systematic Reviews (PROSPERO) with an identifier (CRD42023409614). Results: Twenty-one studies, published between 2009 and 2024, comprising 9319 sepsis patients were included. The pooled proportion of cases diagnosed as positive using ISTH-DIC criteria, JAAM-DIC criteria, and SIC were 28% (95% CI: 24–34%), 55% (95% CI:42–70%), and 57% (95% CI: 52–78%), respectively. The pooled mortality rates were 44% (95% CI:33–53%), 37% (95% CI: 29–46%), and 35% (95% CI: 29–41%), respectively. The pooled sensitivity and specificity of ISTH-DIC to predict mortality were 0.43 (95% CI: 0.34–0.52), and 0.81 (95% CI: 0.74–0.87), respectively, while for JAAM-DIC it was 0.73 (95% CI: 0.57–0.85) and 0.46 (95% CI: 0.28–0.65), respectively. Pooled sensitivity and specificity for SIC were 0.71 (95% CI: 0.57–0.82) and 0.49 (95% CI: 0.31–0.66), respectively. Conclusion: The SIC and JAAM-DIC scores exhibited higher sensitivity to identify patients with coagulopathy and predict patient outcomes, and thus are valuable to identify patients for possible treatment at an early stage. The ISTH-DIC score perhaps identified patients at later stages and demonstrated better specificity to predict disease outcomes. Thus, early identification of patients using the SIC and JAAM-DIC scores and later confirmation using the ISTH-DIC score would be beneficial approach for improved management of patients with sepsis.

1 August 2019 in PLOS ONE
Verified
Journal Article
Open access
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
FZFitsum Mesfin Zewudie
Fitsum Mesfin Zewudie
Anemia is one of the common complications of pregnancy. Hemoglobin concentration, Hematocrit, and Red cell count are laboratory tests used to diagnose anemia. In are source poor setting, there is a practice of using three-fold converted Hematocrit. This study is designed to assess the association and acceptability of three-fold converted Hematocrit as compared to the standard Micro-hematocrit method, in pregnant women. The cross-sectional study conducted from May 18 to June 12, 2018 involved 200 pregnant women who visited the Laboratory for a Hematocrit test. Three milliliter of venous blood was collected with EDTA tube to determine Hematocrit by the Micro-hematocrit method and Hemoglobin concentration measured by a HemoCue Hemoglobin B analyzer. A scatter plot, correlation coefficient, Bland and Altman plot, and Area under curve were employed to assess the agreement and acceptability of the calculated Hematocrit as compared to the standard Micro-hematocrit. The correlation coefficient, Intraclass correlation coefficient and concordance correlation coefficient were 0.91, 0.94, and 0.89, respectively. The Bland and Altman plot showed a mean difference of 0.94 with the limit of agreement ranges from 0.6 to 1.3. The area under the receiver operating characteristics with cut-off point of Hematocrit <33% was 0.86. The sensitivity and specificity of the calculated method was 95.5% and 71.4%, respectively. Generally there is excellent association between the two methods. The two methods were identical within inherent imprecision of both methods. Hence, the Hematocrit value, threefold calculated from the Hemoglobin was found to be acceptable to diagnose anemia in pregnant women.

1 March 2019 in Ethiopian Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
DADebebe Asrat
Debebe Asrat
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
LGLealem Gedefaw
Lealem Gedefaw
WAWondimagegn Addisu
Wondimagegn Addisu
TYTilahun Yemane
Tilahun Yemane
BACKGROUND: Diabetes mellitus is a group of heterogeneous disorders of multiple etiologies characterized by chronic hyperglycemia resulting from defects in insulin secretion and/or insulin action. Diabetes mellitus has been reported to disturb normal hemostasis by various mechanisms. However, data on hemostasis of diabetic patients in the study area are lacking. This study was aimed at determining hemostatic profile and associated factors of hemostatic abnormality in diabetic patients. METHODS: A comparative cross-sectional study was conducted involving a total of 238 (119 diabetic and 119 apparently healthy) individuals who came to the chronic care clinic, Jimma University Specialized Hospital. Socio-demographic and clinical data were collected through a structured questionnaire. A blood sample of 10ml was collected in EDTA (4ml), citrate (3ml) and chemistry (3ml) tubes to do platelet count, coagulation tests, and glucose and lipid profile analysis, respectively. Descriptive statistics as well as the median (25th, 75th) percentile and Mann Whitney U test were used during data analysis. RESULTS: The overall hemostatic abnormality in diabetes individuals was 58.8%. The median (25th, 75th percentile) prothrombin time for diabetic and non-diabetic subjects was (12.8, 15.6) vs. (12.8, 14.2), respectively, and the difference was not statistically significant (p>0.05). The median (25th, 75th percentile) activated partial thromboplastin time was significantly different between the two groups (p<0.0001); (24, 36.8) vs. (36, 39.6). The median (25th, 75th percentile) fibrinogen level was significantly different between the two groups (p<0.0001); (277, 462) vs. (243, 328). The median (25th, 75th percentile) platelet count was also significantly different between the two groups (p<0.0001); (146,248) vs. (190,319). All variables were not significantly associated with hemostatic abnormality in multivariate regression analysis. CONCLUSION: An overall hemostatic abnormality in diabetic patients was found to be high. The APTT and platelet count were lower in diabetic patients whilst the fibrinogen level was higher. Routine coagulation tests should be part of tests among diabetic patients. Advanced coagulation tests should also be considered to identify specific markers so as to pinpoint the particular problem.

17 July 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
BRBirhane Msc Reta
Birhane Msc Reta
AMAbdurehman E. Mohammed
Abdurehman E. Mohammed
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
WAWondimagegn Msc Adissu
Wondimagegn Msc Adissu
TSTilahun Y. Md Shenkute
Tilahun Y. Md Shenkute
Background: Tuberculosis (TB) is a significant public health problem affecting one-third of the world’s population. In 2021, 1.6 million people died from TB. TB is the 13th leading cause of death and the second leading cause of infectious death after coronavirus disease 2019. Most anti-TB drugs affect hematological parameters in patients. Methods: This longitudinal prospective study was conducted from 03 January to 30 December 2019. Patients who completed a course of TB treatment were candidates for analysis. Sputum and blood samples were collected from each study participant and analyzed by the Gene X-pert machine and a HumaCount 30 hematology analyzer (Human GmbH). SPSS version 20 and R programming software version 4.2.3 were used for data analysis. Friedman’s test was used to assess statistical significance. P-values ​​less than 0.05 were considered statistically significant. Results: A total of 148 patients who completed the course of TB treatment correctly were a candidate for final analysis. Ninety-one (61.5%) study participants were male; the median age was 27.6±9.8 years. Moreover, most of the study participants (84.4%) had pulmonary TB. Most of the hematological parameters had changed in the phases of TB treatment. After anti-TB treatment, there is a significant difference in hematological parameters in red blood cell count, hemoglobin concentration, hematocrit percentage, platelet count, and white blood cell count. Conclusion: Anemia and leucopenia are the most significant problems after TB treatment. Regular checking of these parameters is essential for the patient.

1 December 2023 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
DRDereje Abebe Regassa
Dereje Abebe Regassa
GKGirum Tesfaye Tesfaye Kiya
Girum Tesfaye Tesfaye Kiya
RKRegassa Alemu Kebede
Regassa Alemu Kebede
WBWoyesa Beyene
Woyesa Beyene
Background: Diabetes is a chronic metabolic syndrome that is a global public health problem. Studies have used hematological parameters and hemogram-derived markers as predictors of poor glycemic and microvascular complications status in diabetics. However, the tendency to use these parameters is not fully evaluated in our context, and the evidence is inadequate. This study aimed to assess the hematological profiles and prognostic role of hemogram-derived novel markers in diabetes mellitus and its complications among DM patients at Bishoftu General Hospital, Ethiopia. Methods: A comparative cross-sectional study was conducted among 261 participants from June 15 to August 12, 2022. A systematic random sampling technique was used to select participants. Data were collected using structured questionnaires, physical measurements, checklists, and laboratory tests. Hematological parameters and fasting blood glucose levels were determined from blood using Sysmex-XN550 and Cobas C311 analyzers, respectively. Blood smear was used to check Hematology analyzer output, and to screen participants for malaria parasites. Collected data were entered into Epi-data 3.1 and exported to SPSS-25. Data were analyzed by Chi-square, Mann–Whitney U-test, Kruskal–Wallis test, Post hoc test, and ROC curve. A P-value < 0.05 was considered statistically significant. Results: Total WBC, neutrophils, Monocyte, NLR, MLR, MPVLR, and PLR were significantly higher in poor glycemic and complicated T2DM; meanwhile, measured RBC parameters, RBC indices values were significantly lower in poor glycemic and complicated T2DM. The NLR, MLR, MPVLR, PLR, and NLR, MLR, MPVLR, RPR values were identified as predictors of poor glycemic and complication status in diabetic patients, respectively. Conclusion: Significant increment of some hematological parameters and hemogram-derived markers, and their role in predicting poor glycemic and microvascular complications were identified in diabetic patients. Routine screening of hematological parameters and use of hemogram-derived markers for monitoring of altered health status in DM is very important in the improvement of patient quality of life.